Robert E Drake Selected Research

Substance-Related Disorders (Drug Abuse)

1/2023	Assessing Substance Use Disorder Among Social Security Administration Disability Applicants.
10/2021	The effect evaluation of Individual Placement and Support (IPS) for patients with substance use disorders: study protocol for a randomized controlled trial of IPS versus enhanced self-help.
5/2017	The Prevalence of Traumatic Brain Injury Among People With Co-Occurring Mental Health and Substance Use Disorders.
4/2011	Course of smoking and quit attempts among clients with co-occurring severe mental illness and substance use disorders.
1/2011	The Effectiveness of Supported Employment in People With Dual Disorders.
11/2009	Use of integrated dual disorder treatment via assertive community treatment versus clinical case management for persons with co-occurring disorders and antisocial personality disorder.
6/2009	Subtypes of clients with serious mental illness and co-occurring disorders: latent-class trajectory analysis.
10/2007	Management of substance use disorder in schizophrenia patients: current guidelines.
10/2006	Clozapine use and relapses of substance use disorder among patients with co-occurring schizophrenia and substance use disorders.
10/2006	Conduct disorder and antisocial personality disorder in persons with severe psychiatric and substance use disorders.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Robert E Drake Research Topics

Disease

19	Mental Disorders (Mental Disorder) 01/2021 - 10/2003
16	Substance-Related Disorders (Drug Abuse) 01/2023 - 10/2003
6	Schizophrenia (Dementia Praecox) 01/2018 - 10/2003
3	Psychotic Disorders (Schizoaffective Disorder) 09/2015 - 10/2006
2	Alcoholism (Alcohol Abuse) 01/2023 - 09/2010
2	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 01/2018 - 01/2012
2	Bipolar Disorder (Manic Depressive Psychosis) 01/2018 - 10/2003
2	Antisocial Personality Disorder (Antisocial Personality) 11/2009 - 10/2006
1	Epilepsy (Aura) 01/2021
1	Developmental Disabilities (Developmental Disability) 01/2021
1	Traumatic Brain Injuries (Traumatic Brain Injury) 05/2017
1	Tobacco Use Disorder (Nicotine Dependence) 10/2013
1	Mood Disorders (Mood Disorder) 10/2013
1	Conduct Disorder (Conduct Disorders) 10/2006

Drug/Important Bio-Agent (IBA)

3	Antipsychotic Agents (Antipsychotics)IBA 01/2021 - 10/2006
2	SmokeIBA 01/2018 - 04/2011
2	4-aminospiroperidolIBA 11/2009 - 10/2006
2	Clozapine (Clozaril)FDA LinkGeneric 06/2009 - 10/2006
1	Indicators and Reagents (Reagents)IBA 01/2023
1	diethylaminosulfur trifluorideIBA 01/2023
1	Anticonvulsants (Antiepileptic Drugs)IBA 01/2021
1	bis(p-chlorophenyl)acetic acid (DDA)IBA 01/2015
1	Carbon MonoxideIBA 10/2013
1	Bupropion (Wellbutrin)FDA LinkGeneric 04/2011
1	4-O-carboxymethylascochlorinIBA 09/2010
1	BenzodiazepinesIBA 10/2003

Therapy/Procedure

11	Vocational Rehabilitation 01/2021 - 06/2004
3	Institutionalization (Institutionalized Persons) 05/2017 - 02/2006
3	Secondary Prevention 10/2005 - 10/2005
2	Therapeutics 10/2007 - 10/2005
1	Aftercare (After-Treatment) 10/2021
1	Polypharmacy 01/2021
1	Cognitive Training 09/2015
1	Nicotine Replacement Therapy 04/2011